FBLG
Income statement / Annual
Last year (2025), FibroBiologics Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, FibroBiologics Inc's net income was -$18.65 M.
See FibroBiologics Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$832.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$832.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$7.41 M
|
$4.50 M
|
$2.37 M
|
$1.15 M
|
$521.00 K
|
$669.00 K
|
| General & Administrative Expenses |
$9.24 M
|
$9.23 M
|
$6.52 M
|
$3.32 M
|
$1.06 M
|
$500.00 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.24 M
|
$9.23 M
|
$6.52 M
|
$3.32 M
|
$1.06 M
|
$500.00 K
|
| Other Expenses |
-$832.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$15.82 M
|
$13.74 M
|
$8.89 M
|
$4.47 M
|
$1.58 M
|
$1.17 M
|
| Cost And Expenses |
$16.65 M
|
$13.74 M
|
$8.89 M
|
$4.47 M
|
$1.58 M
|
$1.17 M
|
| Interest Income |
$247.00 K
|
$251.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$204.00 K
|
$20.00 K
|
$147.00 K
|
$654.00 K
|
$4.00 K
|
$0.00
|
| Depreciation & Amortization |
$832.00 K
|
$573.00 K
|
$437.00 K
|
$94.00 K
|
$0.00
|
$1.17 M
|
| EBITDA |
-$17.61 M |
-$10.57 M |
-$15.90 M |
-$4.37 M |
-$1.58 M |
$0.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$2.00 M
|
$2.58 M
|
-$7.60 M
|
-$654.00 K
|
-$4.00 K
|
$0.00
|
| Income Before Tax |
-$18.65 M
|
-$11.16 M
|
-$16.49 M
|
-$5.12 M
|
-$1.58 M
|
-$1.17 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$18.65 M
|
-$11.16 M
|
-$16.49 M
|
-$5.12 M
|
-$1.58 M
|
-$1.17 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-8.4 |
-6.8 |
-11.8 |
-3.2 |
-0.974 |
-0.72 |
| EPS Diluted |
-8.4 |
-6.8 |
-11.8 |
-3.2 |
-0.974 |
-0.72 |
| Weighted Average Shares Out |
$2.23 M
|
$1.64 M
|
$1.62 M
|
$1.62 M
|
$1.62 M
|
$1.62 M
|
| Weighted Average Shares Out Diluted |
$2.23 M
|
$1.64 M
|
$1.62 M
|
$1.62 M
|
$1.62 M
|
$1.62 M
|
| Link |
|
|
|
|
|
|
